Real time Form 13D and 13G transaction reports:
- Schedule 13D must be filed within ten days after a person or an organization acquires beneficial ownership of more than 5% of a voting class of a company's equity securities.
- Due to inconsistent filing format, it is highly recommended that you read the orignal filing form.
- Shares have beem adjusted for stock split.
"Insiders might sell their shares for any number of reasons, but they buy them for only one: they think the price will rise"
- Peter Lynch
What is insider trading>>
- Peter Lynch
What is insider trading>>
| Reported DateTime |
Transaction Date |
Type | Company Symbol |
Filed By Symbol |
Shares Owned % Owned |
Shares Vs. Prev Report | View |
| 2024-11-13 4:00 pm Purchase |
2024-09-30 | 13G | Emergent BioSolutions Inc. EBS |
OAK HILL ADVISORS LP | 3,613,338 6.390% |
3,613,338 (New Position) |
Filing History |
| 2024-11-08 5:23 pm Sale |
2024-09-30 | 13G | Emergent BioSolutions Inc. EBS |
CHARLES SCHWAB INVESTMENT MANAGEMENT INC | 2,224,727 4.200% |
-649,257 (-22.59%) |
Filing History |
| 2024-09-10 12:09 pm Sale |
2024-08-31 | 13G | Emergent BioSolutions Inc. EBS |
BLACKROCK INC BLK |
1,968,784 3.700% |
-1,870,591 (-48.72%) |
Filing History |
| 2024-07-08 4:32 pm Sale |
2024-06-30 | 13G | Emergent BioSolutions Inc. EBS |
BLACKROCK INC BLK |
3,839,375 7.300% |
-2,799,039 (-42.16%) |
Filing History |
| 2024-06-07 1:30 pm Sale |
2024-05-31 | 13G | Emergent BioSolutions Inc. EBS |
BLACKROCK INC BLK |
6,638,414 12.700% |
-2,760,783 (-29.37%) |
Filing History |
| 2024-02-13 5:04 pm Purchase |
2023-12-29 | 13G | Emergent BioSolutions Inc. EBS |
The Vanguard Group | 2,974,638 5.730% |
328,272 (+12.40%) |
Filing History |
| 2024-02-09 6:19 pm Purchase |
2023-12-31 | 13G | Emergent BioSolutions Inc. EBS |
CHARLES SCHWAB INVESTMENT MANAGEMENT INC | 2,873,984 5.540% |
2,873,984 (New Position) |
Filing History |
| 2024-01-23 10:52 am Sale |
2023-12-31 | 13G | Emergent BioSolutions Inc. EBS |
STATE STREET CORP STT |
1,062,951 2.050% |
-69,004 (-6.10%) |
Filing History |
| 2024-01-19 2:40 pm Purchase |
2023-12-31 | 13G | Emergent BioSolutions Inc. EBS |
BLACKROCK INC BLK |
9,399,197 18.100% |
17,305 (+0.18%) |
Filing History |
| 2024-01-18 4:16 pm Sale |
2023-12-31 | 13G | Emergent BioSolutions Inc. EBS |
MILLENNIUM MANAGEMENT LLC | 2,095,662 4.000% |
-615,737 (-22.71%) |
Filing History |
| 2023-11-07 3:33 pm Purchase |
2023-10-31 | 13G | Emergent BioSolutions Inc. EBS |
BLACKROCK INC BLK |
9,381,892 18.100% |
2,981,689 (+46.59%) |
Filing History |
| 2023-10-10 11:27 am Sale |
2023-09-30 | 13G | Emergent BioSolutions Inc. EBS |
STATE STREET CORP STT |
1,131,955 2.180% |
-4,686,000 (-80.54%) |
Filing History |
| 2023-10-10 11:07 am Sale |
2023-09-29 | 13G | Emergent BioSolutions Inc. EBS |
The Vanguard Group | 2,646,366 5.110% |
-2,759,908 (-51.05%) |
Filing History |
| 2023-09-07 4:18 pm Purchase |
2023-08-30 | 13G | Emergent BioSolutions Inc. EBS |
MILLENNIUM MANAGEMENT LLC | 2,711,399 5.200% |
2,711,399 (New Position) |
Filing History |
| 2023-09-07 09:38 am Sale |
2023-08-31 | 13G | Emergent BioSolutions Inc. EBS |
BLACKROCK INC BLK |
6,400,203 12.400% |
-2,555,015 (-28.53%) |
Filing History |
| 2023-02-09 11:19 am Purchase |
2022-12-30 | 13G | Emergent BioSolutions Inc. EBS |
The Vanguard Group | 5,406,274 10.840% |
53,322 (+1.00%) |
Filing History |
| 2023-01-26 08:43 am Unchanged |
2022-12-31 | 13G | Emergent BioSolutions Inc. EBS |
BLACKROCK INC BLK |
8,955,218 18.000% |
0 (Unchanged) |
Filing History |
| 2023-01-20 3:00 pm Purchase |
2022-12-31 | 13G | Emergent BioSolutions Inc. EBS |
BLACKROCK INC BLK |
8,955,218 18.000% |
878,317 (+10.87%) |
Filing History |
| 2023-01-10 08:13 am Purchase |
2022-12-31 | 13G | Emergent BioSolutions Inc. EBS |
STATE STREET CORP STT |
5,817,955 11.660% |
2,785,228 (+91.84%) |
Filing History |
| 2022-03-09 08:44 am Sale |
2022-02-28 | 13G | Emergent BioSolutions Inc. EBS |
The Vanguard Group | 5,352,952 10.600% |
-9,079 (-0.17%) |
Filing History |